Clinical Trial

Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer

Study acronym: RPOS+2
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Phase II study; open recruitment, multicentrique. The aim of this clinical research is to evaluate faisability and toxicity of the per-operative radiotherapy using PAPILLON + TM device for localized breast cancers patients over 65 years.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2020-12-17; most recent amendment 2026-01-28.
Status change: Not Yet Recruiting → Recruiting 2021-05-26
Trial Details
NCT Number NCT04680715
Lead Sponsor Centre Antoine Lacassagne
Conditions Localized Breast Cancer
Enrollment 40 participants
Start Date 2021-07-16
Primary Completion 2027-06 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2026-01-29